1,609
Views
5
CrossRef citations to date
0
Altmetric
Diabetes

Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study

, , , , , , ORCID Icon, , ORCID Icon & show all
Pages 45-51 | Received 30 Jul 2020, Accepted 26 Oct 2020, Published online: 16 Nov 2020

References

  • Baruah MP. Insulin pens: the modern delivery devices. J Assoc Physicians India. 2011;59(Suppl):38–40.
  • Friedrichs A, Bohnet J, Korger V, et al. Dose accuracy and injection force of different insulin glargine pens. J Diabetes Sci Technol. 2013;7(5):1346–1353.
  • Friedrichs A, Korger V, Adler S. Injection force of reusable insulin pens: Novopen 4, Lilly Luxura, Berlipen, and ClikSTAR. J Diabetes Sci Technol. 2011;5(5):1185–1190.
  • Marcus A. Diabetes care - insulin delivery in a changing world. Medscape J Med. 2008;10(5):120.
  • Miller KM, Foster NC, Beck RW, et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015;38(6):971–978.
  • Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66–72.
  • American Diabetes Association: Standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S139–S147.
  • Klonoff DC, Nayberg I, Stauder U, et al. Half-unit insulin pens: disease management in patients with diabetes who are sensitive to insulin. J Diabetes Sci Technol. 2017;11(3):623–630.
  • Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther. 2006;28(10):1712–1725. discussion 1710–1711.
  • Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care. 1999;22(1):137–140.
  • Schade DS, Valentine V. To pump or not to pump. Diabetes Care. 2002;25(11):2100–2102.
  • Bariya M, Nayberg I. Analysis of "dose accuracy, injection force, and usability assessment of a new half-unit, prefilled insulin Pen". J Diabetes Sci Technol. 2018;12(2):373–375.
  • Magnotti MA, Rayfield EJ. An analysis of the HumaPen Luxura HD pen: what is the role of 0.5-unit insulin dosing? J Diabetes Sci Technol. 2010;4(2):357–358.
  • Wong M, Abdulnabi R, Fu H. Ease of use of two reusable, half-unit increment dosing insulin pens by adult caregivers of children with type 1 diabetes: a randomized, crossover comparison. J Diabetes Sci Technol. 2013; 7(2):582–583.
  • Lee IT, Liu HC, Liau YJ, et al. Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients. J Eval Clin Pract. 2009;15(4):699–703.
  • Piscopo MA, Chiesa G, Bonfanti R, et al. Quality of life and new devices in the management of type 1 diabetes in children and adolescents. Acta Bio-Medica: Atenei Parmensis. 2003;74(Suppl 1):21–25.
  • Chandran A, Bonafede MK, Nigam S, et al. Adherence to insulin pen therapy is associated with reduction in healthcare costs among patients with type 2 diabetes mellitus. Am Health Drug Benefits. 2015;8(3):148–158.
  • Kudva YC, Ahmann AJ, Bergenstal RM, et al. Approach to using trend arrows in the FreeStyle Libre Flash glucose monitoring systems in adults. J Endocr Soc. 2018;2(12):1320–1337.
  • Aleppo G, Laffel LM, Ahmann AJ, et al. A practical approach to using trend arrows on the Dexcom G5 CGM system for the management of adults with diabetes. J Endocr Soc. 2017;1(12):1445–1460.